These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6734219

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Long term treatment of angina pectoris using Irrigor Fort].
    Arie E, Fagot D.
    Therapeutique; 1973 Nov; 49(9):583-6. PubMed ID: 4600036
    [No Abstract] [Full Text] [Related]

  • 25. [A study on the usefulness of continuous monitoring of myocardial pH in myocardial protection].
    Mashiko K.
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Oct; 34(10):1750-60. PubMed ID: 3805810
    [No Abstract] [Full Text] [Related]

  • 26. Editorial: Myocardial energy metabolism in patients with ischemic heart disease.
    Kübler W.
    Basic Res Cardiol; 1974 Oct; 69(2):105-12. PubMed ID: 4277055
    [No Abstract] [Full Text] [Related]

  • 27. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
    Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H.
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714
    [No Abstract] [Full Text] [Related]

  • 28. [Myocardial revascularization in malignant ventricular tachyarrhythmia--prognostic significance].
    Pleskot M, Parízek P, Hodac M, Haman L, St'ásek J, Cervinka P, Tauchman M.
    Cas Lek Cesk; 2000 Jan 19; 139(1):13-7. PubMed ID: 10750286
    [Abstract] [Full Text] [Related]

  • 29. Myocardial metabolism and anginal threshold in coronary disease after verapamil administration.
    Ferlinz J, Turbow ME, Aronow WS.
    Clin Invest Med; 1980 Jan 19; 3(1-2):101-9. PubMed ID: 7471535
    [No Abstract] [Full Text] [Related]

  • 30. [Ventricular fibrillation in chronic heart disease].
    Pleskot M, Parízek P, Hodac M, Haman L, Stásek J, Cervinka P, Tauchman M.
    Vnitr Lek; 2000 Feb 19; 46(2):80-6. PubMed ID: 11048528
    [Abstract] [Full Text] [Related]

  • 31. [Disorders of myocardial metabolism in coronary heart disease].
    Kübler W.
    Verh Dtsch Ges Kreislaufforsch; 1975 Feb 19; 41():18-29. PubMed ID: 1231308
    [No Abstract] [Full Text] [Related]

  • 32. Myocardial ischemia and angina pectoris: the clinical problem in patients.
    Selwyn AP, Fox KM, Jonathan A, Lavender P, Watson I.
    Herz; 1981 Feb 19; 6(1):62-70. PubMed ID: 7216123
    [Abstract] [Full Text] [Related]

  • 33. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R, Klepzig H, Ostrowski J, Resag K.
    MMW Munch Med Wochenschr; 1983 Feb 25; 125(8):156-8. PubMed ID: 6405248
    [No Abstract] [Full Text] [Related]

  • 34. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ.
    Thromb Haemost; 2009 Apr 25; 101(4):626-34. PubMed ID: 19350104
    [Abstract] [Full Text] [Related]

  • 35. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM, Theissen P, Schneider CA, Kettering K, Voth E, Sechtem U, Schicha H.
    Rays; 1999 Apr 25; 24(1):96-108. PubMed ID: 10358387
    [Abstract] [Full Text] [Related]

  • 36. [Blood content of certain carbohydrate metabolites in myocardial infarct and coronary disease].
    Mazurowa A, Skubiszyńska A, Smarsz C.
    Pol Tyg Lek; 1966 May 02; 21(18):657-60. PubMed ID: 5911190
    [No Abstract] [Full Text] [Related]

  • 37. Symposium on Myocardial Blood Flow in Man--Methods and Significance in Myocardial Disease; Pisa, Italy; June 10-12, 1971. Report of the session on ischemia.
    Bing RJ, Oliver MF, Schwartz A.
    Cardiology; 1972 May 02; 57(1):98-102. PubMed ID: 5037897
    [No Abstract] [Full Text] [Related]

  • 38. [Percutaneous myocardial laser revascularization (PMR), a new therapeutic procedure for patients with refractory angina pectoris].
    Lauer B, Stahl F, Bratanow S, Schuler G.
    Z Kardiol; 2000 May 02; 89 Suppl 7():31-6. PubMed ID: 11098557
    [Abstract] [Full Text] [Related]

  • 39. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K, Jankowski P, Pajak A, Dubiel J, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W.
    Przegl Lek; 2001 May 02; 58(11):956-63. PubMed ID: 11987835
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular effects of morphine in patients with coronary arterial disease.
    Sethna DH, Moffitt EA, Gray RJ, Bussell J, Raymond M, Conklin C, Shell WE, Matloff JM.
    Anesth Analg; 1982 Feb 02; 61(2):109-14. PubMed ID: 7198870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.